Pernod Ricard shares declined by over 3% on Monday after Deutsche Bank lowered its recommendation on the stock to "sell" from "hold," arguing that recent gains have raced ahead of the company's actual fundamentals. The broker points to a roughly 20% year-to-date rally that it views as more positioning-driven than a reflection of improving operating metrics.
Recent results and market response
The downgrade arrives shortly after Pernod Ricard released its first-half fiscal 2026 results, which showed organic sales down 5.9% and underlying EBIT falling 7.5%. Those figures were broadly in line with market expectations. Despite that alignment with consensus, Deutsche Bank concluded the share price recovery lacks a supporting earnings story.
Deutsche Bank's rationale
Analyst Mitch Collett framed his critique around valuation, leverage and the durability of the recovery embedded in consensus forecasts. At 15.2 times calendar year 2026 earnings, Pernod Ricard trades at only about a 14% discount to its European Beverages peers, a gap Deutsche Bank considers too narrow given the company's balance-sheet and growth profile.
Key balance-sheet metrics cited include a net debt/EBITDA ratio of 3.8 times. Management has set a target of reducing that leverage to below 3.0 times by fiscal year 2029, but Deutsche Bank emphasizes that meeting that commitment depends on an earnings rebound, further disposals and strict capital discipline over multiple years, leaving limited tolerance for setbacks in major markets such as China or the U.S.
Questions around the recovery
Deutsche Bank also cautions that the consensus second-half recovery - implying roughly 1.2% organic sales growth - appears to rely heavily on the timing of the Chinese New Year and easier year-on-year comparatives rather than a clear, demand-driven improvement. Management itself described the China outlook as largely technical.
Collett further notes that to secure a sustained re-rating, a deeper reset in profitability and shareholder returns might be necessary. The dividend of 4.70 per share is being maintained but is not growing, free cash flow coverage is tight, and gross margins remain pressured by tariffs and aged-liquid inflation despite a 10% reduction in structural costs.
Alternative view and upside risks
Not all brokers align with Deutsche Bank. Jefferies retains a "buy" rating with a 110 target, arguing the valuation discount and the credibility of the company's efficiency programme warrant a more positive stance. That view, however, requires confidence in the company achieving a 3-6% medium-term growth framework - a level of optimism Deutsche Bank does not extend at current prices.
Deutsche Bank identifies the main upside catalysts as a U.S. restocking cycle and any Chinese policy stimulus that materially improves demand. Until there is clear evidence of a genuine top-line recovery, Deutsche Bank regards the recent relief rally as largely exhausted.
Market positioning
The bank also points out that the recent rebound in the stock appears to have been driven in part by heavy short covering, suggesting the price move was more technical than fundamental.
Investors and market participants remain focused on whether Pernod Ricard can execute on its deleveraging plan and translate cost savings into sustainable margin improvement, or whether macro and regional demand dynamics will constrain progress.